Glenmark gets US FDA nod for marketing oxcarbazapine tabs (PharmaBiz)

Glenmark gets US FDA nod for marketing oxcarbazapine tabs (PharmaBiz)
Glenmark Pharmaceuticals Ltd has received final approval from the US Food and Drug Administration for the marketing the first generic version of trileptal (Oxcarbazepine). The approval is for marketing oxcarbazapine tablets in three strengths 150 mg, 300 mg and 600 mg.

Glenmark receives approval for marketing Oxcarbazepine - Economic Times

Glenmark receives approval for marketing Oxcarbazepine - Economic Times
Glenmark receives approval for marketing OxcarbazepineEconomic Times, India - 37 minutes agoMUMBAI: Glenmark Pharmaceuticals has received the final approval from the US Food and Drug Administration for marketing Oxcarbazepine tablets, …

South Africa: Forum Highlights Growth in Mobile Marketing, Consumer Adoption (AllAfrica.com)

South Africa: Forum Highlights Growth in Mobile Marketing, Consumer Adoption (AllAfrica.com)
The Mobile Marketing Association (MMA), which represents more than 450 member companies worldwide, yesterday, Tuesday, 9 October 2007, opened its two-day Mobile Marketing Forum (MMF) in Barcelona.